NCT00000221
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
- Locations
-
- Treatment Research Center Burlington, Vermont, United States
Clinical trial condition
Narcotic-Related Disorders
Explore clinical trials studying Narcotic-Related Disorders. Study availability and eligibility vary by location and protocol.
1,299 public trials
198 recruiting studies
Narcotic-Related Disorders trial results
Completed
Alternate-Day Buprenorphine. Phase V - 6
NCT00000224
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
- Locations
-
- Treatment Research Center Burlington, Vermont, United States
NCT00000222
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
- Locations
-
- Treatment Research Center Burlington, Vermont, United States
NCT00000226
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
- Locations
-
- Treatment Research Center Burlington, Vermont, United States
NCT00000220
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
- Locations
-
- Treatment Research Center Burlington, Vermont, United States
Active, Not Recruiting
Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk
NCT05657106
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Chemically-Induced Disorders, +36 more
- Locations
-
- University of Kentucky Lexington, Kentucky, United States
Active, Not Recruiting
Promoting HIV Risk Reduction Among People Who Inject Drugs: A Stepped Care Approach Using Contingency Management With PrEP Adherence and Support Services
NCT04738825
- Conditions
- Chemically-Induced Disorders, HIV Prevention Program, Mental Disorders, +4 more
- Locations
-
- Recovery Network of Programs, Inc Bridgeport, Connecticut, United States
- Liberations Program, Inc Bridgeport, Connecticut, United States
- Apex Community Care. Inc. Danbury, Connecticut, United States
- Connecticut Harm Reduction Alliance (GHHRC and SWAN) New Haven, Connecticut, United States
Active, Not Recruiting
Behavioral Pharmacological Examination of a Novel Buprenorphine Induction Method Among Individuals Who Use Fentanyl
NCT06089707
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
- Locations
-
- Johns Hopkins School of Medicine Baltimore, Maryland, United States
Active, Not Recruiting
Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)
NCT04464980
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
- Locations
-
- University of Arkansas for Medical Sciences (UAMS) / Center for Addiction Services and Treatment (CAST) Little Rock, Arkansas, United States
- Tarzana Treatment Centers, Inc. Tarzana, California, United States
- Liberation Programs, Inc. Bridgeport, Connecticut, United States
- Operation PAR Clearwater, Florida, United States
Active, Not Recruiting
Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool
NCT05706311
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +4 more
- Locations
-
- University of Cincinnati Cincinnati, Ohio, United States
- University of Utah Salt Lake City, Utah, United States